OUR PRODUCTS

MOBILE APPS

GENERAL INFO

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Equillium (EQ) Earnings Date & Reports

Equillium Inc is a clinical-stage biotechnology company engaged in developing novel therapeutics to treat severe autoimmune and inflammatory, or immuno-inflammatory, disorders with high unmet medical need... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

EQ is expected to report earnings to fall 46.34% to -21 cents per share on November 18

Q3'25

Est.

$-0.22

Q1'25

Missed

by $0.12

Q4'24

Beat

by $0.15

Q3'24

Missed

by $0.02

Q2'24

Beat

by $0.16

The last earnings report on May 08 showed earnings per share of -40 cents, missing the estimate of -28 cents. With 5.58M shares outstanding, the current market capitalization sits at 40.72M.

View a ticker or compare two or three

Compare

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For EQ
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. EQ showed earnings on May 08, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a developer of products for severe immune-inflammatory disorders

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

2223 Avenida De La Playa

Phone

+1 858 240-1200

Employees

Web

https://www.equilliumbio.com